To include your compound in the COVID-19 Resource Center, submit it here.

FDA won’t send pink slips in August

FDA Commissioner Scott Gottlieb told staff that if the Senate enters recess without reauthorizing medical product user fees, the agency will not send reduction in force

Read the full 262 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE